SECURITIES PURCHASE AGREEMENT (as amended to date)Securities Purchase Agreement • September 19th, 2013 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 19th, 2013 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 18, 2013, between Agenus Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Common Stock ($0.01 Par Value)Underwriting Agreement • January 11th, 2002 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 11th, 2002 Company Industry Jurisdiction
Common Stock ($0.01 Par Value)Underwriting Agreement • January 27th, 2003 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 27th, 2003 Company Industry Jurisdiction
Exhibit 2.2 FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT This FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (this "Amendment") is dated as of March 17, 2004 (the "Effective Date"), by and between ANTIGENICS INC., a Massachusetts corporation and a...Asset Purchase Agreement • April 1st, 2004 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledApril 1st, 2004 Company Industry Jurisdiction
EXHIBIT 10.11 LICENSE AGREEMENT THIS LICENSE AGREEMENT (this "AGREEMENT") is made and entered into this 1st day of March, 1999, by and between DUKE UNIVERSITY, a not-for-profit corporation organized and existing under the laws of the State of North...License Agreement • November 30th, 1999 • Antigenics Inc /De/ • North Carolina
Contract Type FiledNovember 30th, 1999 Company Jurisdiction
RecitalsLease • May 7th, 2004 • Antigenics Inc /De/ • Biological products, (no disgnostic substances)
Contract Type FiledMay 7th, 2004 Company Industry
1 EXHIBIT 10.4 ANTIGENICS INC. INDEMNIFICATION AGREEMENT ------------------------- This Agreement dated ______________________ is between Antigenics Inc. (the "Company"), a Delaware corporation, and ______________________ (the "Indemnitee"), who is...Indemnification Agreement • November 30th, 1999 • Antigenics Inc /De/ • Delaware
Contract Type FiledNovember 30th, 1999 Company Jurisdiction
AGREEMENTEmployment Agreement • February 26th, 2007 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 26th, 2007 Company Industry Jurisdiction
2 3 filing pursuant to such Rule 424(b) (and Rule 434, if applicable) or from and after the time it is first provided to the Underwriters by the Company for such use. The term "Preliminary Prospectus" as used herein means the preliminary prospectus...Purchase Agreement • January 10th, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 10th, 2000 Company Industry Jurisdiction
MiNK Therapeutics, Inc. (a Delaware corporation) 3,333,334 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 28th, 2021 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 28th, 2021 Company Industry Jurisdiction
EXHIBIT 4.2 ANTIGENICS INC. REGISTRATION RIGHTS AGREEMENT January 25, 2005 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (the "Agreement") is made and entered into as of January 25, 2005, by and among Antigenics Inc., a Delaware...Registration Rights Agreement • January 25th, 2005 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 25th, 2005 Company Industry Jurisdiction
LEASELease Agreement • January 8th, 2003 • Antigenics Inc /De/ • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 8th, 2003 Company Industry
Exhibit 10.1 This Agreement is dated June 21, 2004 and is made between Antigenics Therapeutics Limited having its registered offices at 25/28 North Wall Quay, Dublin 1 Registered No. 381308 ("The Company") and Peter Thornton of Dublin, Ireland ("Chief...Employment Agreement • August 9th, 2004 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 9th, 2004 Company Industry Jurisdiction
RECITALSSublease Agreement • August 13th, 2002 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 13th, 2002 Company Industry Jurisdiction
AMONGMerger Agreement • April 24th, 2001 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 24th, 2001 Company Industry Jurisdiction
WITNESSETHLicense Agreement • February 3rd, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Florida
Contract Type FiledFebruary 3rd, 2000 Company Industry Jurisdiction
AGENUS INC. Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • October 18th, 2017 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 18th, 2017 Company Industry JurisdictionAgenus Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
FORM OF WARRANT] NEITHER THIS WARRANT NOR THE SHARES OF COMMON STOCK FOR WHICH IT IS EXERCISABLE HAVE BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY APPLICABLE STATE OR FOREIGN SECURITIES LAWS...Warrant Agreement • January 24th, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJanuary 24th, 2000 Company Industry Jurisdiction
AMENDMENT AGREEMENT The Letter Agreement of June 3, 1998 between Antigenics L.L.C. and Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. is hereby amended as follows: -ON PAGE 1, THE INITIAL SIX LINES: "Gentlemen: We refer to our recent discussions...Amendment Agreement • January 10th, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 10th, 2000 Company Industry
RECITALSLicense Agreement • August 27th, 2003 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Connecticut
Contract Type FiledAugust 27th, 2003 Company Industry Jurisdiction
AGREEMENTEmployment Agreement • February 26th, 2007 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 26th, 2007 Company Industry Jurisdiction
AGENUS INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • July 22nd, 2020 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 22nd, 2020 Company Industry Jurisdiction
RECITALS:Patent License Agreement • February 3rd, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 3rd, 2000 Company Industry Jurisdiction
EXHIBIT 10.5 CUMMINGS PROPERTIES MANAGEMENT, INC. STANDARD FORM COMMERCIAL LEASE In consideration of the covenants herein contained, Cummings Properties Management, Inc., hereinafter called LESSOR, does hereby lease to ANTIGENICS, L.L.C. (A DE...Commercial Lease • November 30th, 1999 • Antigenics Inc /De/ • New York
Contract Type FiledNovember 30th, 1999 Company Jurisdiction
INDENTUREIndenture • November 27th, 2001 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledNovember 27th, 2001 Company Industry Jurisdiction
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • May 10th, 2013 • Agenus Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 10th, 2013 Company Industry JurisdictionTHIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of April 15, 2013 (the “Effective Date”) among (a) SILICON VALLEY BANK, a California corporation with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”), and (b) AGENUS INC., a Delaware corporation (“Agenus”) and ANTIGENICS INC., a Massachusetts corporation (“Antigenics”) (Agenus and Antigenics are individually and collectively, jointly and severally, “Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:
EXHIBIT 10.7 MASTER LOAN AND SECURITY AGREEMENT Master Loan and Security Agreement No. S7020, dated November 19, 1998 FINOVA TECHNOLOGY FINANCE, INC. ("we," "us" or "FINOVA") is willing to make a loan (the "Loan") to ANTIGENICS, LLC ("you" or...Master Loan and Security Agreement • January 24th, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Arizona
Contract Type FiledJanuary 24th, 2000 Company Industry Jurisdiction
SUBSCRIPTION AGREEMENT FOR LIMITED PARTNERSHIP INTEREST IN APPLIED GENOMIC TECHNOLOGY CAPITAL FUND, L.P.Subscription Agreement • August 14th, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 14th, 2000 Company Industry Jurisdiction
IT IS AGREED:Research Agreement • March 31st, 2005 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Connecticut
Contract Type FiledMarch 31st, 2005 Company Industry Jurisdiction
RECITALSStockholder Voting Agreement • April 24th, 2001 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 24th, 2001 Company Industry Jurisdiction
ANDAsset Purchase Agreement • April 1st, 2004 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledApril 1st, 2004 Company Industry Jurisdiction
RECITALSRight of First Refusal Agreement • May 27th, 2004 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 27th, 2004 Company Industry Jurisdiction
RECITALSLicense Agreement • May 15th, 2003 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Connecticut
Contract Type FiledMay 15th, 2003 Company Industry Jurisdiction
WITNESSETH:Employment Agreement • November 30th, 1999 • Antigenics Inc /De/ • New York
Contract Type FiledNovember 30th, 1999 Company Jurisdiction
AGENUS INC. 19,335,653 Shares of Common Stock1 UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2014 • Agenus Inc • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledFebruary 6th, 2014 Company Industry Jurisdiction